Elsevier . Other. New. Elsevier ISBN 0323548350 9780323548359 [US]

Elsevier 11/26/2018 12: 00: 00 AM Softcover PLEASE NOTE, WE DO NOT SHIP TO DENMARK. New Book. Shipped from US in 4 to 14 days. Established seller since 2000. Please note we cannot offer an expedited shipping service from the US.

ISBN10: 0323548350, ISBN13: 9780323548359, [publisher: Elsevier Science Health Science] Softcover 1st edition. 185 pages. 9.00x7.25x0.50 inches. In Stock.
[Exeter, United Kingdom] [Publication Year: 2018]

Paperback / softback. New. Get a quick, expert overview of the ways in which biomarkers can be used to assess and guide the management of cardiovascular disease in the clinical setting. This concise, clinically-focused resource by Dr. Vijay Nambi consolidates today's available information on this rapidly changing topic into one convenient resource, making it an ideal, easy-to-digest reference for cardiology practitioners, fellows, and residents. Covers lab standards and statistical interpretation of biomarkers with a clinical focus. Discusses relevant conditions such as hypertension and diabetes as key markers of injury and prognosis. Includes current information on biomarkers to assess and guide the management of heart failure, acute coronary syndrome, chest pain, shortness of breath, and more. Concludes the book with a timely chapter on how biomarkers may guide cardiologists in the future. ISBN 0323548350 9780323548359 [GB]

Elsevier 2018 Trade paperback New. Trade paperback (US). Glued binding. 198 p. Contains: Illustrations, color.

Very Good. ISBN 0323548350 9780323548359 [US]

Elsevier (Np), Date: 2019. New. 2019. Elsevier (Np) ISBN 0323548350 9780323548359 [IN]